Prescribed By :Diabetologist, General Physician, Endocrinologist, Cardiologist
Product Description
Key Benefits of Glimighty-DM 1000
Reduces hepatic glucose output and improves insulin sensitivity
Does not stimulate insulin secretion, so no hypoglycaemia when used alone
Stimulates insulin release from functioning pancreatic beta cells
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch
Indications of Glimighty-DM 1000
Type 2 diabetes mellitus
Type 2 diabetes inadequately controlled on diet and exercise
Type 2 diabetes inadequately controlled on single-agent therapy
Insulin resistance in type 2 diabetes
Fasting hyperglycaemia
How Glimighty-DM 1000 works
Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP Eq. to Dapagliflozin 10 mg + Glimepiride I.P. 2 mg Metformin Hydrochloride I.P. 1000 mg (As Extended release) - Glimighty-DM 1000 is part of Cista Medicorp's Anti Diabetic range. Detailed mechanism of action and clinical information is available on request from our medical team.
Why ChooseGlimighty-DM 1000?
Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.
Frequently asked questions about Glimighty-DM 1000
Is monopoly available for this product?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
What is the composition of Glimighty-DM 1000?
Each film coated bilayered tablet contains: Dapagliflozin Propanediol USP Eq. to Dapagliflozin 10 mg + Glimepiride I.P. 2 mg Metformin Hydrochloride I.P. 1000 mg (As Extended release).
Is this manufactured at a WHO-GMP certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.
What is the minimum order quantity?
Please contact our team for the current MOQ and price structure for your territory.
Last updated on 29 August 2026
This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.